MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Free cash flow 2022–2025
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$196.0MFY2025 · since FY2022: -$55.9M → -$196.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$196.0M | -67.4% |
| FY2024 | -$117.1M | -171.9% |
| FY2023 | -$43.1M | +23.0% |
| FY2022 | -$55.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice